546 related articles for article (PubMed ID: 11640874)
1. Molecular cytogenetics.
Kearney L
Best Pract Res Clin Haematol; 2001 Sep; 14(3):645-69. PubMed ID: 11640874
[TBL] [Abstract][Full Text] [Related]
2. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
[TBL] [Abstract][Full Text] [Related]
3. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies.
Maciejewski JP; Tiu RV; O'Keefe C
Br J Haematol; 2009 Sep; 146(5):479-88. PubMed ID: 19563474
[TBL] [Abstract][Full Text] [Related]
4. Role of cytogenetics and molecular cytogenetics in the diagnosis of genetic imbalances.
Dave BJ; Sanger WG
Semin Pediatr Neurol; 2007 Mar; 14(1):2-6. PubMed ID: 17331878
[TBL] [Abstract][Full Text] [Related]
5. Molecular cytogenetics in metaphase and interphase cells for cancer and genetic research, diagnosis and prognosis. Application in tissue sections and cell suspensions.
Mühlmann M
Genet Mol Res; 2002 Jun; 1(2):117-27. PubMed ID: 14963837
[TBL] [Abstract][Full Text] [Related]
6. Detection of numerical aberrations in hematologic neoplasias by fluorescence in situ hybridization.
Cuneo A; Bigoni R; Roberti MG; Bardi A; Balsamo R; Piva N; Castoldi G
Haematologica; 1997; 82(1):85-90. PubMed ID: 9107092
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of current molecular cytogenetic protocols for the diagnosis of chromosome aberrations in tumor specimens.
Lichter P; Fischer K; Joos S; Fink T; Baudis M; Potkul RK; Ohl S; Solinas-Toldo S; Weber R; Stilgenbauer S; Bentz M; Döhner H
Cytokines Mol Ther; 1996 Sep; 2(3):163-9. PubMed ID: 9384700
[TBL] [Abstract][Full Text] [Related]
8. Emerging molecular cytogenetic technologies.
Chang SS; Mark HF
Cytobios; 1997; 90(360):7-22. PubMed ID: 9438335
[TBL] [Abstract][Full Text] [Related]
9. [Chromosomal in situ hybridization and interphase cytogenetics in single cell and tissue section preparations: new methods in tumor diagnosis and clinical cytogenetics].
Ott G; Peters K; Roblick U; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1994; 78():111-23. PubMed ID: 7533973
[TBL] [Abstract][Full Text] [Related]
10. [Strategies to identify supernumerary chromosomal markers in constitutional cytogenetics].
Douet-Guilbert N; Basinko A; Le Bris MJ; Herry A; Morel F; De Braekeleer M
Pathol Biol (Paris); 2008 Sep; 56(6):362-7. PubMed ID: 18456432
[TBL] [Abstract][Full Text] [Related]
11. [Multicolor fluorescence in situ hybridization (mFISH].
Michalová K; Zemanová Z; Brezinová J
Cas Lek Cesk; 2001 Mar; 140(4):99-103. PubMed ID: 11284431
[TBL] [Abstract][Full Text] [Related]
12. A cytogeneticist's perspective on genomic microarrays.
Shaffer LG; Bejjani BA
Hum Reprod Update; 2004; 10(3):221-6. PubMed ID: 15140869
[TBL] [Abstract][Full Text] [Related]
13. [Delineating a supernumerary marker chromosome by combining several cytogenetic and molecular cytogenetic techniques].
Tan YQ; Di YF; Song YZ; Cheng DH; Li LY; Lu GX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):392-6. PubMed ID: 17680527
[TBL] [Abstract][Full Text] [Related]
14. Quantitative FISH by image cytometry for the detection of chromosome 1 imbalances in breast cancer: a novel approach analyzing chromosome rearrangements within interphase nuclei.
Truong K; Guilly MN; Gerbault-Seureau M; Malfoy B; Vielh P; Bourgeois CA; Dutrillaux B
Lab Invest; 1998 Dec; 78(12):1607-13. PubMed ID: 9881960
[TBL] [Abstract][Full Text] [Related]
15. Rapid prenatal diagnosis of Down syndrome using quantitative fluorescence in situ hybridization on interphase nuclei.
Truong K; Gibaud A; Dupont JM; Guilly MN; Soussaline F; Dutrillaux B; Malfoy B
Prenat Diagn; 2003 Feb; 23(2):146-51. PubMed ID: 12575023
[TBL] [Abstract][Full Text] [Related]
16. FISH panels for hematologic malignancies.
Sreekantaiah C
Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
[TBL] [Abstract][Full Text] [Related]
18. Advances in molecular cytogenetics for the evaluation of mental retardation.
Xu J; Chen Z
Am J Med Genet C Semin Med Genet; 2003 Feb; 117C(1):15-24. PubMed ID: 12561054
[TBL] [Abstract][Full Text] [Related]
19. Fluorescent in situ hybridization as an adjunct to conventional cytogenetics.
Mark HF
Ann Clin Lab Sci; 1994; 24(2):153-63. PubMed ID: 8203823
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetics and fluorescence in-situ hybridization in detection of hematological malignancies.
Frenny VJ; Antonella Z; Luisa A; Shah AD; Sheth JJ; Rocchi M
Indian J Cancer; 2003; 40(4):135-9. PubMed ID: 14716109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
